Companies House · 03690299

NAPP PHARMACEUTICALS LIMITED

UK registered company, private limited company, incorporated 22 Dec 1998.

Active

50
Public contracts: 0
Spend payments: —
Total spend

NAPP PHARMACEUTICALS LIMITED is a UK company registered at Companies House under number 03690299. This page links its registry record to its activity in UK public procurement — the contracts it has been awarded and the transparency-spend payments recorded against it.

Companies House record

Company number: 03690299
Status: Active
Company type: Private Limited Company
Incorporated: 22 Dec 1998
Country of origin: United Kingdom
Registered office: UNIT 191 CAMBRIDGE SCIENCE PARK, CAMBRIDGE, CB4 0GW, ENGLAND
Nature of business (SIC): 46460 - Wholesale of pharmaceutical goods
Accounts category: FULL

View source on data.gov.uk

Public sector contracts

Contract awards linked to NAPP PHARMACEUTICALS LIMITED.

Procurement	Buyer	Awarded	Value
Invitation to offer for NHS Framework Agreement for Branded Medicines - Proprietary Category Tender - 01 May 2025	NHS England	—	—
NHS Framework Agreement, Branded Medicines for London and South of England and Bevacizumab for North of England and Midlands and East	NHS England	—	—
NHS Framework Agreement, Branded Medicines for London and South of England and Bevacizumab for North of England and Midlands and East	NHS England	—	—
NHS Framework Agreement, Branded Medicines for London and South of England and Bevacizumab for North of England and Midlands and East	NHS England	—	—
NHS Framework Agreement, Branded Medicines for London and South of England and Bevacizumab for North of England and Midlands and East	NHS England	—	—
NHS Framework Agreement, Branded Medicines for London and South of England and Bevacizumab for North of England and Midlands and East	NHS England	—	—
NHS Framework Agreement for Branded Medicines – National	NHS England	—	—
NHS National Generic Pharmaceuticals Wave 13	The NHS Commissioning Board (operating under the name of NHS England)	—	—
NHS Framework for the Midlands and East, Branded Medicines – Tranche A and Annual Tranche	The NHS Commissioning Board (operating under the name of NHS England)	—	—
NHS Framework for the Midlands and East, Branded Medicines – Tranche A and Annual Tranche	The NHS Commissioning Board (operating under the name of NHS England)	—	—
Invitation to offer for NHS Framework for the North of England, Branded Medicines – Tranche B, Annual Tranche and Insulin Aspart Biosimilar (Trurapi®)	The NHS Commissioning Board (operating under the name of NHS England)	—	—
Invitation to offer for NHS Framework for the North of England, Branded Medicines – Tranche B, Annual Tranche and Insulin Aspart Biosimilar (Trurapi®)	The NHS Commissioning Board (operating under the name of NHS England)	—	—
NHS Framework Agreement for Branded Medicines - National Tender	NHS England	—	—
NHS National Pharmaceuticals Transition 2022_1	NHS England	—	—
NHS National Proprietary Category Tender - 1 May 2024	NHS England	—	—
NHS Framework Agreement for Branded Medicines – Tranche A London and South of England and Adult Influenza (National) - 01 September 2025	NHS England	—	—
NHS National Pharmaceuticals Transition 2021_3	The NHS Commissioning Board (operating under the name of NHS England)	—	—
NHS Branded Medicines Tranche Framework for London and South of England - 1 September 2024	NHS England	—	—
Oncology Generics Medicines	The Common Services Agency (more commonly known as NHS National Services Scotland) ("the Authority")	—	—
Cardiovascular & Respiratory Medicines	The Common Services Agency (more commonly known as NHS National Services Scotland) ("the Authority")	—	—
Cardiovascular & Respiratory Medicines	The Common Services Agency (more commonly known as NHS National Services Scotland) ("the Authority")	—	—
Generic Medicines Transition Tender	The Common Services Agency (more commonly known as NHS National Services Scotland) ("the Authority")	—	—
NP40923 Analgesics, Anaesthetics, Musculoskeletal & Joint Disease Medicines	The Common Services Agency (more commonly known as NHS National Services Scotland) ("the Authority")	—	—
NP40923 Analgesics, Anaesthetics, Musculoskeletal & Joint Disease Medicines	The Common Services Agency (more commonly known as NHS National Services Scotland) ("the Authority")	—	—
NP40923 Analgesics, Anaesthetics, Musculoskeletal & Joint Disease Medicines	The Common Services Agency (more commonly known as NHS National Services Scotland) ("the Authority")	—	—
NP40923 Analgesics, Anaesthetics, Musculoskeletal & Joint Disease Medicines	The Common Services Agency (more commonly known as NHS National Services Scotland) ("the Authority")	—	—
NP40923 Analgesics, Anaesthetics, Musculoskeletal & Joint Disease Medicines	The Common Services Agency (more commonly known as NHS National Services Scotland) ("the Authority")	—	—
NP40923 Analgesics, Anaesthetics, Musculoskeletal & Joint Disease Medicines	The Common Services Agency (more commonly known as NHS National Services Scotland) ("the Authority")	—	—
NHS Framework for the Midlands and East, Branded Medicines – Tranche B plus Cytokine Modulators and other Monoclonal Antibodies.	The NHS Commissioning Board (operating under the name of NHS England)	—	—
NHS Framework for the Midlands and East, Branded Medicines – Tranche B plus Cytokine Modulators and other Monoclonal Antibodies.	The NHS Commissioning Board (operating under the name of NHS England)	—	—
NHS Framework, North of England, Branded Medicines - Tranche A and Annual Tranche	The NHS Commissioning Board (operating under the name of NHS England)	—	—
NHS Framework, North of England, Branded Medicines - Tranche A and Annual Tranche	The NHS Commissioning Board (operating under the name of NHS England)	—	—
NHS Framework Agreement for Branded Medicines - National Proprietary Pharmaceuticals - 1 May 2023	NHS England	—	—
NHS South of England Branded Medicines - Tranche A - September 2023	NHS England	—	—
Medicinal Products Dynamic Purchasing System (131864)	Procurement & Logistics Service	—	—
Medicinal Products Dynamic Purchasing System (131864)	Regional Business Services Organisation, Procurement and Logistics Service	—	—
Medicinal Products Dynamic Purchasing System (131864)	Regional Business Services Organisation, Procurement and Logistics Service	—	—
NHS Branded Medicines Framework for North of England and Midlands and East of England - 1 March 2024	NHS England	—	—
NHS Branded Medicines Framework for North of England and Midlands and East of England - 1 March 2024	NHS England	—	—
NP40925 Analgesics, Anaesthetics, Musculoskeletal & Joint Disease Medicines	The Common Services Agency (more commonly known as NHS National Services Scotland) ("the Authority")	—	—
NP40925 Analgesics, Anaesthetics, Musculoskeletal & Joint Disease Medicines	The Common Services Agency (more commonly known as NHS National Services Scotland) ("the Authority")	—	—
NP40925 Analgesics, Anaesthetics, Musculoskeletal & Joint Disease Medicines	The Common Services Agency (more commonly known as NHS National Services Scotland) ("the Authority")	—	—
NP40925 Analgesics, Anaesthetics, Musculoskeletal & Joint Disease Medicines	The Common Services Agency (more commonly known as NHS National Services Scotland) ("the Authority")	—	—
NP40925 Analgesics, Anaesthetics, Musculoskeletal & Joint Disease Medicines	The Common Services Agency (more commonly known as NHS National Services Scotland) ("the Authority")	—	—
NP40925 Analgesics, Anaesthetics, Musculoskeletal & Joint Disease Medicines	The Common Services Agency (more commonly known as NHS National Services Scotland) ("the Authority")	—	—
NP40925 Analgesics, Anaesthetics, Musculoskeletal & Joint Disease Medicines	The Common Services Agency (more commonly known as NHS National Services Scotland) ("the Authority")	—	—
Medicinal Products and Pharma Funded Homecare Services	Procurement and Logistics Service	—	—
Medicinal Products and Pharma Funded Homecare Services	Procurement and Logistics Service	—	—
Medicinal Products and Pharma Funded Homecare Services	Procurement and Logistics Service	—	—
Medicinal Products and Pharma Funded Homecare Services (5315742) - Pre - Market Engagement	Regional Business Services Organisation Procurement and Logistics Service	—	—

Supplier identities

How this company appears as a supplier across the data.

FAQs about NAPP PHARMACEUTICALS LIMITED

Is NAPP PHARMACEUTICALS LIMITED an active company?

NAPP PHARMACEUTICALS LIMITED (company number 03690299) is recorded as "Active", incorporated on 22 Dec 1998.

What does NAPP PHARMACEUTICALS LIMITED do?

Its Companies House nature-of-business (SIC) is: 46460 - Wholesale of pharmaceutical goods.

Has NAPP PHARMACEUTICALS LIMITED won UK public-sector contracts?

Yes — 50 public-sector contract awards are linked to this company in our data.

Where is NAPP PHARMACEUTICALS LIMITED based?

Its registered office is UNIT 191 CAMBRIDGE SCIENCE PARK, CAMBRIDGE, CB4 0GW, ENGLAND.

Understand any company's public-sector footprint

Enable links Companies House to live procurement and spend data — see contracts, buyers and payments for any UK supplier.

Get in touch with Enable